3rd Circ. Asked To Revive Allergan Product-Hopping Suit
A pharmacy chain made a final bid Tuesday to persuade the Third Circuit to revive a product-hopping suit against Allergan over eye care products Zymar and Zymaxid, insisting that it has...To view the full article, register now.
Already a subscriber? Click here to view full article